NEWSLETTER

By clicking submit, you agree to share your email address with TFN to receive marketing, updates, and other emails from the site owner. Use the unsubscribe link in the emails to opt out at any time.

Ex-Bain operators raise $17M to tackle behavioural healthcare’s data blind spot with AI

Onos Health founders
Image credits: Onos Health
  • Onos Health has raised $17 million in Series A funding led by Costanoa, with CVS Health Ventures and Flare Capital Partners joining less than a year after its previous round.
  • The AI platform is live with Aetna and three of the six largest US health plans, claiming to cut behavioural health program costs by more than 6% within 12 months.
  • CEO Akshay Agrawal spent years advising the health plans he now sells to, at Bain & Company and Bain Capital, before founding Onos in 2024.

Akshay Agrawal spent years on the other side of the pitch meeting, advising health plan executives at Bain & Company on how to run their businesses better. Now, those same executives are paying his company to fix a problem he watched them struggle with from the inside: behavioural health data that is too messy for legacy systems to use.

Onos Health has raised $17 million in Series A funding led by Costanoa, with Flare Capital Partners and CVS Health Ventures joining as investors. 

The round follows a $6.3 million raise Onos closed in October 2025, co-led by Haystack and Pathlight Ventures with Bertelsmann Healthcare Investments and Nebular participating, meaning the company has now raised roughly $23.3 million in under a year.

Turning clinical records into actionable intelligence

Behavioral health has become the fastest-growing cost driver for many US health plans since the pandemic, and direct medical costs already exceed $140 billion a year in the country. More than 23% of US adults experience a mental health condition annually, yet health plans still lean on manual, retrospective chart reviews to judge whether care was appropriate.

Onos says more than 70% of the signals plans need to assess care quality sit in unstructured documentation, including session notes, treatment plans, and assessments, which its AI models are built to parse. 

Instead of a plan waiting months for a retrospective audit to catch a provider drifting from clinical guidelines, Onos says its platform flags the pattern in near real time. 

The company reports a 35% improvement in clinical standard adherence, a 75% improvement in review efficiency, and a reduction of more than 6% in behavioural health program costs within 12 months.

Behavioral health data platforms sit adjacent to a broader and increasingly crowded value-based care analytics market, where Innovaccer and HealthEdge already sell payer-facing tools. 

Unlike competitors, Onos trained its models specifically on behavioural health documentation, a category that larger vendors have historically folded into broader utilisation-management products rather than treated as a distinct discipline.

A founder who used to sit across the table

Onos was founded in San Francisco in 2024 by Agrawal, Josh Levitan, and Suhaas Prasad, and now has 18 employees. 

Agrawal’s background is squarely payer-side: after Bain & Company, he moved to Bain Capital, investing in care delivery platforms, then took operating roles at mPulse, a member-engagement platform for health plans, and Presence, a virtual behavioural health provider for children and schools. 

Levitan brings 15-plus years of building technology for health plans and government healthcare programs, including Medicaid initiatives such as Hawaii Med-QUEST and Wisconsin BadgerCare.

That pedigree appears to be exactly what drew CVS Health Ventures in. The strategic investor has previously backed Thyme Care, an AI-powered cancer care navigation startup that became a unicorn on a $97 million raise, and Simile, a Stanford spinout that closed $200 million months after its Series A, both signs that CVS’s venture arm favours founders who can move from early traction to expansion quickly.

Investors see infrastructure opportunity

“Behavioral health care quality is difficult to understand and manage because it is recorded in unstructured clinical documentation which legacy solutions cannot process. AI has the potential to fundamentally transform how health plans manage care by making clinical quality and care pathways measurable at scale,” said Agrawal, co-founder and CEO of Onos Health. 

“Behavioural health is one of the largest and least understood categories in healthcare,” said Amy Cheetham, partner at Costanoa. She said the company is building “critical foundational infrastructure for behavioural health care” that has historically been overlooked.

CVS Health Ventures also sees an opportunity to improve how health plans interpret complex behavioural health data. “Onos Health helps surface actionable clinical insights from data that has historically been difficult to interpret,” added Alyssa Reisner, vice president and general partner at CVS Health Ventures.

“Onos is giving health plans the behavioural health clinical intelligence they need to move from reactive oversight to value-driven healthcare. Health plans using Onos’ AI-powered platform are seeing significant improvement in clinical quality and affordability, and we are excited to partner with Akshay and the team as they build the category,” concluded Margaret Malone, partner at Flare Capital Partners. 

Two funding rounds inside a year is a signal. What Onos still has to demonstrate is whether AI trained on clinical documentation can shift outcomes and costs across a large, diverse population of health plans, or whether, like many category-defining bets in payer tech, the hardest part is not the model but getting entrenched health plans to change how they work.

Total
0
Shares
Related Posts
Total
0
Share
tfn-logo-2-220x220-removebg-preview

Get daily funding news briefings in the tech world delivered right to your inbox.

Enter Your Email
join our newsletter. thank you
TFN Banner